Description
Telgard-M 50 Tablet, manufactured by Cipla Ltd., is a combination antihypertensive medicine that provides effective control of high blood pressure (hypertension) and reduces risks of heart-related complications.
It combines two proven agents:
-
Telmisartan (40mg): An angiotensin II receptor blocker (ARB) that prevents blood vessels from tightening, helping them relax and widen. This lowers blood pressure and improves circulation.
-
Metoprolol Succinate (50mg): A beta-blocker that decreases heart rate, reduces the heart’s oxygen demand, and lowers cardiac workload.
This dual action makes Telgard-M 50 suitable for patients who require stronger therapy when single medications are insufficient.
Medical Uses
-
Management of essential hypertension
-
Reduces risks of stroke, heart attack, and heart failure
-
Helps in patients with left ventricular dysfunction or post-cardiac events
-
Provides long-term cardiovascular protection
Benefits
-
Enhanced blood pressure control through dual-action mechanism
-
Reduces stress on the heart and arteries
-
Lowers long-term risk of cardiac and vascular complications
-
Convenient once-daily dosing for better compliance
-
Suitable for patients not controlled with lower doses like Telgard-M 25
Possible Side Effects
-
Dizziness, headache, or fatigue
-
Low blood pressure (hypotension)
-
Slow heartbeat (bradycardia)
-
Cold extremities, mild swelling, or sleep disturbances
-
Rare but serious: breathing difficulty, worsening of asthma, or abnormal heart rhythm
Warnings & Precautions
-
Avoid in pregnancy and breastfeeding (may harm the fetus/baby)
-
Use cautiously in patients with asthma, COPD, liver or kidney problems
-
Do not stop suddenly—may cause rebound hypertension or angina
-
Regular monitoring of BP, pulse, kidney function, and electrolytes is advised
-
Alcohol may intensify side effects like dizziness or fainting
Leave a Reply